banter and General Discussion, page-10822

Neither Nippy, nor SI or John Hester or Louise Chen from Gerald Fitz Cantor has any idea of the schedule for the FDA to deal with the resubmitted BLA or what the result may be. It depends on what other work they have to complete, availability of employees as well as the assessment itself. For SI to suggest it will completed early is just more of his puffery designed to incite investors. You'd think HC readers would be used to it after all these misleading statements, but no, they swallow it down like starving peasants.